Bozik
Ended Awarded Last action
- Contract number
- 75N95019F00088
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $487,204
Award facts
- Opportunity
-
- NIHNINDS1601 Solicitation number
- Pharmacology and Toxicology for Therapeutics Program (PTTP) Award Notice · Posted Mar 4, 2016
- Contract value 54% obligated
-
- $487,204.23 Current, with exercised options
- $904,600.23 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$10,618 | |
| Change Order | $84,616 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $9,132 | |
| Original award | $404,074 |
About this award
This federal contract award is an Indefinite Delivery/Indefinite Quantity (IDIQ) parent award for the Pharmacology and Toxicology for Therapeutics Program (PTTP) administered by the National Institute on Drug Abuse, a civilian agency. The contract was awarded to SRI International, a non-profit research and development institute, and does not have a set-aside designation.
The purpose of this award is to de-obligate unexpended and expiring Fiscal Year 2020 funding in preparation for the September 30, 2025 closing of the period of availability for these funds, in accordance with 31 U.S.C. Section 1552(a). The contract has a ceiling value of $904,600.23 and a performance period that extends through September 12, 2026. As an IDIQ parent award, this contract provides a flexible mechanism for the agency to access SRI International's specialized technical capabilities in areas such as pharmacology, toxicology, and therapeutics development.
Quick answers
Who was awarded contract 75N95019F00088?
75N95019F00088 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on May 23, 2019.
How much is contract 75N95019F00088 worth?
The government has obligated $487,204 on 75N95019F00088. Its potential value, with all options, is $904,600.
Is contract 75N95019F00088 an order under another contract?
Yes. 75N95019F00088 is a delivery order under HHSN271201600006I, an indefinite delivery contract, on Pharmacology and Toxicology for Therapeutics Program (PTTP).
Was contract 75N95019F00088 competed?
The extent of competition for 75N95019F00088 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award